Document is current
Any future updates will be listed below
-
Authors
Manousou, Sofia
Olsson, Anders
Mamasoula, Zoi
Saran, Mina Abdi
Oleröd, Göran
Filipsson Nyström, Helena
-
Funding
Funding for this research was provided by:
University of Gothenburg
- License Information
-
More Information
Article History
Received: 17 June 2025
Accepted: 16 April 2026
First Online: 28 April 2026
Declarations
:
: This study was approved by the regional Ethical Review Board in Gothenburg, Sweden (Dnr:2019 − 00795), and was performed according to the Declaration of Helsinki. We did not need to ask patients for individual informed consent as no additional blood was taken and as TRAb-IM and TRAb-KR assays target the TSH receptor. Information about the study was displayed at the Thyroid and Isotope Units during the sampling period.
: Not applicable.
: Helena Filipsson Nyström has lecture fees from Siemens Healthcare, Oripharm, BMS, and IBSA; was the manager for the National Task Force for Hyperthyroidism in Sweden; and is a Guideline Board Member of European Thyroid Association and the Thyroid Task Force at the Endocrine Society for Endocrinology. The other authors declare no potential conflicts of interest.
